MX2009008875A - Producto que contiene probiotico inactivado para niños o infantes. - Google Patents
Producto que contiene probiotico inactivado para niños o infantes.Info
- Publication number
- MX2009008875A MX2009008875A MX2009008875A MX2009008875A MX2009008875A MX 2009008875 A MX2009008875 A MX 2009008875A MX 2009008875 A MX2009008875 A MX 2009008875A MX 2009008875 A MX2009008875 A MX 2009008875A MX 2009008875 A MX2009008875 A MX 2009008875A
- Authority
- MX
- Mexico
- Prior art keywords
- children
- inactivated probiotic
- probiotic
- infants
- product containing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Se describe un producto para niños o infantes que comprende por lo menos un probiótico inactivado, en donde el producto se formula para suministrar entre aproximadamente 1x104 a aproximadamente 1x1010 equivalentes celulares de probiótico inactivado por kg de peso corporal por día a un niño o infante, y en donde, además de las características reproductivas, por lo menos un probiótico inactivado conserva las características reactivas biológicas celulares y moleculares del probiótico viable.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US90412207P | 2007-02-28 | 2007-02-28 | |
PCT/US2008/054717 WO2008106373A1 (en) | 2007-02-28 | 2008-02-22 | Product containing inactivated probiotic for children or infants |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2009008875A true MX2009008875A (es) | 2009-08-28 |
Family
ID=39469924
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2009008875A MX2009008875A (es) | 2007-02-28 | 2008-02-22 | Producto que contiene probiotico inactivado para niños o infantes. |
MX2009009119A MX2009009119A (es) | 2007-02-28 | 2008-02-22 | Metodo para tratar o prevenir la inflamacion sistemica. |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2009009119A MX2009009119A (es) | 2007-02-28 | 2008-02-22 | Metodo para tratar o prevenir la inflamacion sistemica. |
Country Status (14)
Country | Link |
---|---|
US (2) | US9408818B2 (es) |
EP (2) | EP2124977B9 (es) |
CN (3) | CN101636172A (es) |
AT (1) | ATE544457T1 (es) |
BR (2) | BRPI0808052A2 (es) |
CA (2) | CA2676956C (es) |
ES (2) | ES2388198T5 (es) |
HK (2) | HK1136969A1 (es) |
MX (2) | MX2009008875A (es) |
MY (2) | MY145769A (es) |
PL (2) | PL2114423T3 (es) |
RU (2) | RU2468807C2 (es) |
TW (2) | TWI494114B (es) |
WO (2) | WO2008106372A1 (es) |
Families Citing this family (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7767203B2 (en) | 1998-08-07 | 2010-08-03 | Ganeden Biotech, Inc. | Methods for the dietary management of irritable bowel syndrome and carbohydrate malabsorption |
CN101636172A (zh) * | 2007-02-28 | 2010-01-27 | 美赞臣营养品公司 | 用于儿童或婴幼儿的含有灭活益生菌的产品 |
CA2707656C (en) * | 2007-12-06 | 2018-05-22 | Arla Foods Amba | Probiotic bacteria and regulation of fat storage |
MY160376A (en) * | 2008-11-03 | 2017-03-15 | Nestec Sa | A nutritional composition comprising probiotics and improving sleep patterns |
WO2010127132A1 (en) * | 2009-04-29 | 2010-11-04 | Ganeden Biotech, Inc. | Inactivated bacterial cell formulation |
EP2429538B1 (en) * | 2009-05-11 | 2015-10-21 | Nestec S.A. | Non-replicating bifidobacterium longum ncc2705 and immune disorders |
EP2251020A1 (en) * | 2009-05-11 | 2010-11-17 | Nestec S.A. | Short-time high temperature treatment generates microbial preparations with anti-inflammatory profiles |
EP2251022A1 (en) * | 2009-05-11 | 2010-11-17 | Nestec S.A. | Non-replicating micro-organisms and their immune boosting effect |
BR112012017978A2 (pt) * | 2010-01-19 | 2016-05-03 | Abbott Lab | fórmulas nutricionais contendo simbióticos |
WO2011130487A1 (en) | 2010-04-14 | 2011-10-20 | Ganeden Biotech, Inc. | Probiotic confection and lipid compositions |
EP2455094A1 (en) | 2010-11-11 | 2012-05-23 | Nestec S.A. | Non-replicating probiotic micro-organisms protect children against gastrointestinal infections |
EP2455093A1 (en) * | 2010-11-11 | 2012-05-23 | Nestec S.A. | Non-replicating probiotic bacteria and prevention or treatment of infections in children |
EP2452576A1 (en) * | 2010-11-11 | 2012-05-16 | Nestec S.A. | Extruded non-replicating probiotic micro-organisms and their health benefits |
BR112013010783A2 (pt) | 2010-11-11 | 2016-07-12 | Nestec Sa | confecções congeladas contendo micro-organismos probióticos |
EP2455092A1 (en) * | 2010-11-11 | 2012-05-23 | Nestec S.A. | Non-replicating probiotic micro-organisms protect against upper respiratory tract infections |
US11235008B2 (en) | 2011-03-31 | 2022-02-01 | Ganeden Biotech, Inc. | Probiotic sports nutrition compositions |
GB201112091D0 (en) | 2011-07-14 | 2011-08-31 | Gt Biolog Ltd | Bacterial strains isolated from pigs |
GB201117313D0 (en) | 2011-10-07 | 2011-11-16 | Gt Biolog Ltd | Bacterium for use in medicine |
KR101166798B1 (ko) * | 2011-12-19 | 2012-07-26 | 김대현 | 락토바실러스 애시도필러스 엘비의 사균을 포함하는 알레르기 질환의 치료 또는 예방용 의약 조성물 |
WO2013103826A1 (en) * | 2012-01-06 | 2013-07-11 | Skyview Enterprise Ltd. | Anti-inflammatory compounds in combination with hydrogen for the treatment of inflammation |
US20130251829A1 (en) * | 2012-03-23 | 2013-09-26 | Mead Johnson Nutrition Company | Probiotic derived non-viable material for infection prevention and treatment |
GB201306536D0 (en) | 2013-04-10 | 2013-05-22 | Gt Biolog Ltd | Polypeptide and immune modulation |
CA2920461C (en) * | 2013-08-09 | 2023-01-03 | Ab-Biotics, S.A. | Probiotic for infantile excessive crying |
EP3091861A1 (en) * | 2013-11-25 | 2016-11-16 | Nestec S.A. | Heat-treated formulation of bifidobacterium lactis ncc 2818 reduces allergic manifestations |
RU2687038C1 (ru) * | 2013-11-29 | 2019-05-06 | Нестек С.А. | Соответствующие возрастным потребностям питательные композиции с различным содержанием белка |
MX2017008449A (es) | 2014-12-23 | 2017-10-12 | 4D Pharma Res Ltd | Polipeptido de pirina y modulacion inmune. |
CN113862175A (zh) | 2014-12-23 | 2021-12-31 | 4D制药研究有限公司 | 免疫调控 |
MA41060B1 (fr) | 2015-06-15 | 2019-11-29 | 4D Pharma Res Ltd | Compositions comprenant des souches bactériennes |
CA2988695A1 (en) | 2015-06-15 | 2016-12-22 | 4D Pharma Research Limited | Compositions comprising bacterial strains |
CN114984057A (zh) | 2015-06-15 | 2022-09-02 | 4D制药研究有限公司 | 包含细菌菌株的组合物 |
MA41010B1 (fr) | 2015-06-15 | 2020-01-31 | 4D Pharma Res Ltd | Compositions comprenant des souches bactériennes |
AU2016278067B2 (en) | 2015-06-15 | 2022-09-22 | Cj Bioscience, Inc. | Compositions comprising bacterial strains |
GB201520497D0 (en) | 2015-11-20 | 2016-01-06 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
PT3209310T (pt) | 2015-11-20 | 2018-04-20 | 4D Pharma Res Ltd | Composições compreendendo estirpes bacterianas |
GB201520638D0 (en) | 2015-11-23 | 2016-01-06 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
GB201520631D0 (en) | 2015-11-23 | 2016-01-06 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
GB201612191D0 (en) | 2016-07-13 | 2016-08-24 | 4D Pharma Plc | Compositions comprising bacterial strains |
CA3016179C (en) | 2016-03-04 | 2019-08-13 | 4D Pharma Plc | Compositions comprising bacterial blautia strains for treating visceral hypersensitivity |
TWI802545B (zh) | 2016-07-13 | 2023-05-21 | 英商4D製藥有限公司 | 包含細菌菌株之組合物 |
ES2657665B1 (es) * | 2016-09-05 | 2018-12-17 | Pedro Jose DE LA FUENTE BLASCO | Productos para la salud con probióticos inactivados y uso de dichos productos |
GB201621123D0 (en) | 2016-12-12 | 2017-01-25 | 4D Pharma Plc | Compositions comprising bacterial strains |
CN107115362A (zh) * | 2017-04-28 | 2017-09-01 | 青岛东海药业有限公司 | 凝结芽孢杆菌在制备预防或治疗支气管哮喘制剂中的应用 |
PL3630136T3 (pl) | 2017-05-22 | 2021-09-13 | 4D Pharma Research Limited | Kompozycje zawierające szczepy bakteryjne |
WO2018215782A1 (en) | 2017-05-24 | 2018-11-29 | 4D Pharma Research Limited | Compositions comprising bacterial strain |
DK3600364T3 (da) | 2017-06-14 | 2020-08-31 | 4D Pharma Res Ltd | Sammensætninger omfattende en bakteriestamme af slægten megasphaera og anvendelser deraf |
WO2018229188A1 (en) | 2017-06-14 | 2018-12-20 | 4D Pharma Research Limited | Compositions comprising bacterial strains |
CN108041607A (zh) * | 2017-12-26 | 2018-05-18 | 广州普正生物科技有限公司 | 一种护齿益生菌咀嚼软胶囊 |
RU2770463C1 (ru) * | 2020-10-14 | 2022-04-18 | федеральное государственное бюджетное образовательное учреждение высшего образования "Алтайский государственный технический университет им. И.И. Ползунова" (АлтГТУ) | Способ производства мягкого сыра |
TWI802009B (zh) * | 2021-09-16 | 2023-05-11 | 創百股份有限公司 | 使用熱致死的乳酸菌菌株來治療和/或預防微粒物質-誘發的肺損傷 |
Family Cites Families (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5804179A (en) * | 1985-12-31 | 1998-09-08 | Research Corporation Technologies, Inc. | Lactobacillus compositions and methods for treating urinary tract infections |
RU2031586C1 (ru) * | 1993-02-05 | 1995-03-27 | Тамара Георгиевна Извекова | Биологически активный кисломолочный продукт "ацидолакт-наринэ" и способ его получения |
US6156320A (en) * | 1993-02-05 | 2000-12-05 | Harry Parsekian | Fermented milk nutraceuticals |
US6180100B1 (en) * | 1994-09-30 | 2001-01-30 | Urex Biotech., Inc. | Lactobacillus compositions and methods for treating urinary tract infections |
FI104465B (fi) * | 1995-06-14 | 2000-02-15 | Valio Oy | Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö |
EP0965643B1 (en) * | 1998-06-17 | 2003-11-05 | Societe Des Produits Nestle S.A. | Mobile genetic elements as tools for genetic modification of L. delbrueckii or L. helveticus |
US6399055B1 (en) * | 1998-10-27 | 2002-06-04 | Compagnie Gervais Danone | Method and composition for treatment of infant diarrhea |
BR9916062A (pt) * | 1998-12-11 | 2002-09-24 | Urex Biotech Inc | Administração oral de lactobacillus para o tratamento e prevenção de infecção urogenital |
ID29150A (id) * | 1999-01-15 | 2001-08-02 | Entpr Ireland Cs | Penggunaan lactobacillus salivarius |
WO2001058465A2 (en) | 2000-02-10 | 2001-08-16 | Gregor Reid | Probiotic therapy for newborns |
IL156490A0 (en) * | 2000-12-18 | 2004-01-04 | Probiohealth | Probiotic compounds derived from lactobacillus casei strain ke01 |
KR100419132B1 (ko) * | 2000-12-29 | 2004-02-18 | 조성근 | 위·장 점막 부착성과 증식성, 내산성, 내담즙성 및헬리코박터 파일로리, 대장균 0157:h7에 대한 항균성이우수한 락토바실러스 파라카제이 서브스패시즈 파라카제이csk 01 |
FI109602B (fi) * | 2001-01-25 | 2002-09-13 | Valio Oy | Probioottiyhdistelmä |
DE60222856T2 (de) * | 2001-02-06 | 2008-07-24 | Société des Produits Nestlé S.A. | Endotoxin-bindung durch milchsäurebakterien und bifidobacteria |
PE20030274A1 (es) * | 2001-07-26 | 2003-05-08 | Alimentary Health Ltd | Cepas de lactobacillus salivarius |
PE20030283A1 (es) * | 2001-07-26 | 2003-05-01 | Alimentary Health Ltd | Cepas de lactobacillus casei |
PE20030284A1 (es) * | 2001-07-26 | 2003-05-01 | Alimentary Health Ltd | Cepas de bifidobacterium |
EP1364586A1 (en) * | 2002-05-24 | 2003-11-26 | Nestec S.A. | Probiotics and oral tolerance |
US20050100531A1 (en) * | 2002-06-13 | 2005-05-12 | John Bienenstock | Probiotic therapies |
EP1565547B2 (en) * | 2002-06-28 | 2012-09-19 | Biosearch S.A. | Probiotic strains, a process for the selection of them, compositions thereof, and their use |
US20050180962A1 (en) | 2003-01-30 | 2005-08-18 | Eyal Raz | Inactivated probiotic bacteria and methods of use thereof |
US20040208863A1 (en) * | 2003-01-30 | 2004-10-21 | James Versalovic | Anti-inflammatory activity from lactic acid bacteria |
EP1608383A1 (en) * | 2003-03-31 | 2005-12-28 | Alimentary Health Limited | A formulation comprising a bacterial strain |
CA2532472C (en) * | 2003-06-23 | 2012-04-17 | Nestec S.A. | Infant or follow-on formula |
WO2005085287A1 (en) * | 2004-03-03 | 2005-09-15 | En-N-Tech, Inc. | Treatments for contaminant reduction in lactoferrin preparations and lactoferrin-containing compositions |
CA2559390A1 (en) * | 2004-03-15 | 2005-09-22 | Tissugen Pty Ltd | Infectious aetiology of prostatic disease and methods to identify causative agents |
EP2308566B1 (en) * | 2005-04-08 | 2017-07-05 | The Procter and Gamble Company | Use of orally administered probiotic bifidobacteria for human beauty benefits |
US8377430B2 (en) | 2005-04-13 | 2013-02-19 | Nestec S.A. | Infant formula with probiotics |
US20060233762A1 (en) * | 2005-04-15 | 2006-10-19 | Mcmahon Robert J | Method for treating or preventing systemic inflammation in formula-fed infants |
US20060233752A1 (en) * | 2005-04-15 | 2006-10-19 | Mcmahon Robert J | Method for treating or preventing systemic inflammation in formula-fed infants |
WO2006124630A2 (en) * | 2005-05-13 | 2006-11-23 | New England Medical Center Hospitals, Inc. | Compositions and methods for enhancing the efficacy of vaccines |
CN101636172A (zh) * | 2007-02-28 | 2010-01-27 | 美赞臣营养品公司 | 用于儿童或婴幼儿的含有灭活益生菌的产品 |
-
2008
- 2008-02-22 CN CN200880006384A patent/CN101636172A/zh active Pending
- 2008-02-22 AT AT08730501T patent/ATE544457T1/de active
- 2008-02-22 MX MX2009008875A patent/MX2009008875A/es active IP Right Grant
- 2008-02-22 US US12/035,705 patent/US9408818B2/en active Active
- 2008-02-22 BR BRPI0808052-6A2A patent/BRPI0808052A2/pt not_active IP Right Cessation
- 2008-02-22 BR BRPI0808145-0A patent/BRPI0808145A2/pt not_active Application Discontinuation
- 2008-02-22 CA CA2676956A patent/CA2676956C/en active Active
- 2008-02-22 EP EP08730501A patent/EP2124977B9/en not_active Revoked
- 2008-02-22 US US12/035,718 patent/US9408819B2/en active Active
- 2008-02-22 CA CA2679374A patent/CA2679374C/en active Active
- 2008-02-22 RU RU2009135871/15A patent/RU2468807C2/ru not_active IP Right Cessation
- 2008-02-22 ES ES08730508T patent/ES2388198T5/es active Active
- 2008-02-22 RU RU2009135873/15A patent/RU2468808C2/ru not_active IP Right Cessation
- 2008-02-22 EP EP08730508.2A patent/EP2114423B2/en active Active
- 2008-02-22 PL PL08730508T patent/PL2114423T3/pl unknown
- 2008-02-22 PL PL08730501T patent/PL2124977T3/pl unknown
- 2008-02-22 CN CN200880006326.8A patent/CN101678053B/zh active Active
- 2008-02-22 MX MX2009009119A patent/MX2009009119A/es active IP Right Grant
- 2008-02-22 ES ES08730501T patent/ES2381232T3/es active Active
- 2008-02-22 MY MYPI20092999A patent/MY145769A/en unknown
- 2008-02-22 CN CN201610186303.6A patent/CN105796607A/zh active Pending
- 2008-02-22 WO PCT/US2008/054710 patent/WO2008106372A1/en active Application Filing
- 2008-02-22 MY MYPI20093000 patent/MY151892A/en unknown
- 2008-02-22 WO PCT/US2008/054717 patent/WO2008106373A1/en active Application Filing
- 2008-02-27 TW TW097106847A patent/TWI494114B/zh active
- 2008-02-27 TW TW097106849A patent/TWI418355B/zh not_active IP Right Cessation
-
2010
- 2010-05-05 HK HK10104424.6A patent/HK1136969A1/xx unknown
- 2010-09-01 HK HK10108287.3A patent/HK1141729A1/zh unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY151892A (en) | Product containing inactivated probiotic for infants | |
NZ612472A (en) | Nutritional compositions comprising human milk oligosaccharides and nucleotides and uses thereof for treating and/or preventing enteric viral infection | |
WO2007000762A3 (en) | Baby and toddler carrier | |
PH12014501749B1 (en) | A nutritional composition comprising probiotics and improving sleep patterns | |
MX339112B (es) | Formula alimenticia para bebes y niños pequeños que comprenden probioticos para bebes y niños pequeños. | |
MX2009011931A (es) | Articulos para incontinencia del adulto, desechables y especificos de genero. | |
NZ612386A (en) | Synbiotic combination of probiotic and human milk oligosaccharides to promote growth of beneficial microbiota | |
NZ613180A (en) | Methods of using human milk oligosaccharides for improving airway respiratory health | |
WO2009099971A3 (en) | Modular feeding bottle | |
MY156779A (en) | Absorbent article | |
PL1871400T3 (pl) | Kwas uronowy i probiotyki | |
TW200612971A (en) | Method for preventing or treating respiratory infections and acute otitis media in infants | |
MY151518A (en) | Carrying device | |
NZ612105A (en) | Human milk oligosaccharides for modulating inflammation | |
TW200600543A (en) | Process for the production of porous moulded articles containing alginate | |
MX338195B (es) | Preparaciones de anticuerpos. | |
MY162708A (en) | Use of selected lactic acid bacteria for reducing infantile colic | |
MX347403B (es) | Composiciones anti-regurgitacion y/o anti-reflujo gastroesofagico, preparacion y usos. | |
MXPA05008432A (es) | Formula y sistema de alimentacion para bebes. | |
MXPA06003117A (es) | Formula infantil. | |
CN201755321U (zh) | 一种防摔婴儿用奶瓶 | |
CN202698550U (zh) | 前背式婴儿背带 | |
WO2010010553A3 (en) | Insulating and singing doll cover for baby feeding bottles | |
WO2006116117A3 (en) | A harness | |
曹丹 et al. | From Lullaby to Requiem |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration | ||
GB | Transfer or rights |